{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:33:32Z","timestamp":1792740812186,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI17C0335"],"award-info":[{"award-number":["HI17C0335"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1335-x","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T04:05:17Z","timestamp":1540958717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies"],"prefix":"10.1186","volume":"15","author":[{"given":"Haeng-Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarosh","family":"Irani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/brain\/awg045","volume":"126","author":"D Kidd","year":"2003","unstructured":"Kidd D, Burton B, Plant GT, Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain. 2003;126:276\u201384.","journal-title":"Brain"},{"key":"1335_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","volume":"261","author":"A Petzold","year":"2014","unstructured":"Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol. 2014;261:17\u201326.","journal-title":"J Neurol"},{"key":"1335_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/WCO.0000000000000446","volume":"30","author":"M Reindl","year":"2017","unstructured":"Reindl M, Jarius S, Rostasy K, Berger T. Myelin oligodendrocyte glycoprotein antibodies: how clinically useful are they? Curr Opin Neurol. 2017;30:295\u2013301.","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"1335_CR4","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","volume":"2","author":"Sung-Min Kim","year":"2015","unstructured":"Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A, Lee KW, Waters P. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm. 2015;2:e163.","journal-title":"Neurology - Neuroimmunology Neuroinflammation"},{"key":"1335_CR5","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1212\/NXI.0000000000000131","volume":"2","author":"K Chalmoukou","year":"2015","unstructured":"Chalmoukou K, Alexopoulos H, Akrivou S, Stathopoulos P, Reindl M, Dalakas MC. Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm. 2015;2:e131.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1335_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302.","journal-title":"Ann Neurol"},{"key":"1335_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177.","journal-title":"Neurology"},{"key":"1335_CR8","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1001\/archneur.64.10.1426","volume":"64","author":"J de Seze","year":"2007","unstructured":"de Seze J, Debouverie M, Zephir H, Lebrun C, Blanc F, Bourg V, Wiertlewski S, Pittion S, Laplaud D, Le Page E. Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol. 2007;64:1426.","journal-title":"Arch Neurol"},{"issue":"8","key":"1335_CR9","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1177\/1352458516674366","volume":"23","author":"Sung-Min Kim","year":"2016","unstructured":"Kim S, Waters P, Woodhall M, Kim Y, Kim J, Cheon S, Lee S, Jo S, Kim D, Jung K. Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G. Mult Scler. 2016:1104\u201311.","journal-title":"Multiple Sclerosis Journal"},{"key":"1335_CR10","doi-asserted-by":"publisher","first-page":"e0162900","DOI":"10.1371\/journal.pone.0162900","volume":"11","author":"J Yang","year":"2016","unstructured":"Yang J, Kim S, Kim Y, Cheon S, Kim B, Jung K, Park K. Accuracy of the fluorescence-activated cell sorting assay for the aquaporin-4 antibody (AQP4-ab): comparison with the commercial AQP4-ab assay kit. PLoS One. 2016;11:e0162900.","journal-title":"PLoS One"},{"key":"1335_CR11","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O'Connor KC, Reindl M, Lang B, Sato DK, Jurynczyk M, Tackley G, Rocha J, Takahashi T, et al. MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm. 2015;2:e89.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1335_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1352458515587751","volume":"22","author":"C Fernandez-Carbonell","year":"2016","unstructured":"Fernandez-Carbonell C, Vargas-Lowy D, Musallam A, Healy B, McLaughlin K, Wucherpfennig K, Chitnis T. Clinical and MRI phenotype of children with MOG antibodies. Mult Scler. 2016;22:174.","journal-title":"Mult Scler"},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/WNO.0b013e318283c3ed","volume":"33","author":"M Storoni","year":"2013","unstructured":"Storoni M, Davagnanam I, Radon M, Siddiqui A, Plant GT. Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system. J Neuroophthalmol. 2013;33:123\u20137.","journal-title":"J Neuroophthalmol"},{"key":"1335_CR14","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1177\/1352458513510223","volume":"20","author":"A Benoilid","year":"2014","unstructured":"Benoilid A, Tilikete C, Collongues N, Arndt C, Vighetto A, Vignal C, de Seze J. Relapsing optic neuritis: a multicentre study of 62 patients. Mult Scler. 2014;20:848.","journal-title":"Mult Scler"},{"key":"1335_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","volume":"81","author":"A Petzold","year":"2009","unstructured":"Petzold A, Pittock SJ, Lennon V, Maggiore C, Weinshenker B, Plant GT, IgG NMO. (Aquaporin-4) autoantibodies in immune-mediated optic neuritis. J Neurol Neurosurg Psychiatry. 2009;81:109.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1335_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/NRL.0000000000000122","volume":"22","author":"T Chang","year":"2017","unstructured":"Chang T, Waters P, Woodhall M, Vincent A. Recurrent optic neuritis associated with MOG antibody seropositivity. Neurologist. 2017;22:101\u20132.","journal-title":"Neurologist"},{"key":"1335_CR17","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","volume":"1","author":"S Ramanathan","year":"2014","unstructured":"Ramanathan S, Reddel SW, Henderson A, Parratt JD, Barnett M, Gatt PN, Merheb V, Kumaran RY, Pathmanandavel K, Sinmaz N, et al. Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm. 2014;1:e40.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1335_CR18","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1212\/WNL.0b013e31824f8069","volume":"78","author":"S Kim","year":"2012","unstructured":"Kim S, Kim W, Li X, Jung I, Kim H. Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology. 2012;78:1179.","journal-title":"Neurology"},{"key":"1335_CR19","doi-asserted-by":"crossref","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume L, H\u00fcmmert M. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016;13:280.","DOI":"10.1186\/s12974-016-0718-0"},{"issue":"12","key":"1335_CR20","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"Maciej Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140:3128\u201338.","journal-title":"Brain"},{"key":"1335_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/jnnp-2014-310206","volume":"87","author":"T Akaishi","year":"2016","unstructured":"Akaishi T, Sato DK, Nakashima I, Takeshita T, Takahashi T, Doi H, Kurosawa K, Kaneko K, Kuroda H, Nishiyama S, et al. MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry. 2016;87:446\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1335_CR22","doi-asserted-by":"publisher","first-page":"e0170847","DOI":"10.1371\/journal.pone.0170847","volume":"12","author":"H Stiebel-Kalish","year":"2017","unstructured":"Stiebel-Kalish H, Lotan I, Brody J, Chodick G, Bialer O, Marignier R, Bach M, Hellmann MA. Retinal nerve fiber layer may be better preserved in MOG-IgG versus AQP4-IgG optic neuritis: a cohort study. PLoS One. 2017;12:e0170847.","journal-title":"PLoS One"},{"key":"1335_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fimmu.2017.00529","volume":"8","author":"P Peschl","year":"2017","unstructured":"Peschl P, Bradl M, H\u00f6ftberger R, Berger T, Reindl M. Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases. Front Immunol. 2017;8:529.","journal-title":"Front Immunol"},{"key":"1335_CR24","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Chiriboga A, Majed M, Fryer J, Dubey D, McKeon A, Flanagan E, Jitprapaikulsan J, Kothapalli N, Tillema J, Chen J. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol. 2018.","DOI":"10.1001\/jamaneurol.2018.1814"},{"key":"1335_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1212\/WNL.0000000000002844","volume":"87","author":"JJ Wang","year":"2016","unstructured":"Wang JJ, Jaunmuktane Z, Mummery C, Brandner S, Leary S, Trip SA. Inflammatory demyelination without astrocyte loss in MOG antibody\u2013positive NMOSD. Neurology. 2016;87:229.","journal-title":"Neurology"},{"key":"1335_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00401-016-1559-8","volume":"132","author":"S Kinzel","year":"2016","unstructured":"Kinzel S, Lehmann-Horn K, Torke S, Hausler D, Winkler A, Stadelmann C, Payne N, Feldmann L, Saiz A, Reindl M, et al. Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen. Acta Neuropathol. 2016;132:43\u201358.","journal-title":"Acta Neuropathol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1335-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1335-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1335-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:06:04Z","timestamp":1572465964000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1335-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1335-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of Seoul National University Hospital in Korea (approval number H-1012-080-344). The study protocol followed the tenets of the Declaration of Helsinki. All subjects signed written informed consent for use of material and clinical information for research purposes.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"302"}}